References
- Yosipovitch G, Bernhard JD. Clinical practice. Chronic pruritus. N Engl J Med. 2013;368:1625–34.
- Kini SP, DeLong LK, Veledar E, et al. The impact of pruritus on quality of life: the skin equivalent of pain. Arch Dermatol. 2011;147:1153–6.
- Kwinter J, Pelletier J, Khambalia A, Pope E. High-potency steroid use in children with vitiligo: a retrospective study. J Am Acad Dermatol. 2007;56:236–41.
- Ikoma A, Steinhoff M, Stander S, et al. The neurobiology of itch. Nat Rev Neurosci. 2006;7:535–47.
- Nolen TM. Sedative effects of antihistamines: safety, performance, learning, and quality of life. Clin Ther. 1997;19:39–55. discussion 32-33.
- Kopecky EA, Jacobson S, Bch MB, et al. Safety and pharmacokinetics of EMLA in the treatment of postburn pruritus in pediatric patients: a pilot study. J Burn Care Rehabil. 2001;22:235–42.
- Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
- Ebell MH, Siwek J, Weiss BD, et al. Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature. Am Fam Physician. 2004;69:548–56.
- Allenby CF, Johnstone RS, Chatfield S, et al. PERINAL – a new no-touch spray to relieve the symptoms of pruritus ani. Int J Colorectal Dis. 1993;8:184–7.
- Young TA, Patel TS, Camacho F, et al. A pramoxine-based anti-itch lotion is more effective than a control lotion for the treatment of uremic pruritus in adult hemodialysis patients. J Dermatolog Treat. 2009;20:76–81.
- Freeman CW. A new topical remedy useful in the management of pruritus. J Natl Med Assoc. 1961;53:151–3.
- Sandroni P. Central neuropathic itch: a new treatment option? Neurology. 2002;59:778–9.
- Layton AM, Cotterill JA. Notalgia paraesthetica – report of three cases and their treatment. Clin Exp Dermatol. 1991;16:197–8.
- Poterucha TJ, Murphy SL, Davis MD, et al. Topical amitriptyline-ketamine for the treatment of brachioradial pruritus. JAMA Dermatol. 2013;149:148–50.
- Griffin JR, Davis MD. Amitriptyline/ketamine as therapy for neuropathic pruritus and pain secondary to herpes zoster. J Drugs Dermatol. 2015;14:115–8.
- Poterucha TJ, Murphy SL, Sandroni P, et al. Topical amitriptyline combined with topical ketamine for the management of recalcitrant localized pruritus: a retrospective pilot study. J Am Acad Dermatol. 2013;69:320–1.
- Perinal cutaneous spray: package insert, information for the user. In: Ltd FL, ed. Hitchin, UK: Dermal Laboratories; 2014.
- Lidamantle HC Cream. Package insert. 2013. Available from https://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=141551. Accessed September 9, 2016.
- Emla (Lidocaine and Prilocaine) cream: package insert. 2005. Available from http://www.akorn.com/documents/catalog/sell_sheets/63323-289-55.pdf. Accessed September 9, 2016.
- Lidoderm (lidocaine patch 5%): package insert. 2004. Available from http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020612s007lbl.pdf. Accessed September 9, 2016.
- SARNA – pramoxine hydrochloride lotion. Human OTC Drug Label. 2016. Available from https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6fe48995-0b1c-48dd-bc6e-5d41b31a6486. Accessed September 9, 2016.
- Andrew D, Craig AD. Spinothalamic lamina I neurons selectively sensitive to histamine: a central neural pathway for itch. Nat Neurosci. 2001;4:72–7.
- Schmelz M. A neural pathway for itch. Nat Neurosci. 2001;4:9–10.
- Yosipovitch G, Tur E, Morduchowicz G, Boner G. Skin surface pH, moisture, and pruritus in haemodialysis patients. Nephrol Dial Transplant. 1993;8:1129–32.